576 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 12 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
KCND1Potassium voltage-gated channel subfamily D member 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
NucleusMixed
KCND2Potassium voltage-gated channel subfamily D member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel subfamily D member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNE1Potassium voltage-gated channel subfamily E regulatory subunit 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
KCNH2Potassium voltage-gated channel subfamily H member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ1Potassium voltage-gated channel subfamily J member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ11Potassium voltage-gated channel subfamily J member 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ12Potassium voltage-gated channel subfamily J member 12FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Golgi apparatus
Cytosol
Group enriched
KCNJ8Potassium voltage-gated channel subfamily J member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK2Potassium two pore domain channel subfamily K member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNK3Potassium two pore domain channel subfamily K member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK9Potassium two pore domain channel subfamily K member 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNMA1Potassium calcium-activated channel subfamily M alpha 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNN4Potassium calcium-activated channel subfamily N member 4Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium voltage-gated channel subfamily Q member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel subfamily Q member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enriched
KCNQ3Potassium voltage-gated channel subfamily Q member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KDRKinase insert domain receptorCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
KEAP1Kelch like ECH associated protein 1Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Microtubule organizing center
Cytosol
Expressed in all
KITKIT proto-oncogene receptor tyrosine kinaseCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
KLKB1Kallikrein B1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
LCKLCK proto-oncogene, Src family tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Golgi apparatusTissue enhanced
LHCGRLuteinizing hormone/choriogonadotropin receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
LIPFLipase F, gastric typeEnzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
LPLLipoprotein lipaseCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhanced
MAOAMonoamine oxidase ADisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
MitochondriaMixed
MAOBMonoamine oxidase BEnzymes
FDA approved drug targets
Predicted membrane proteins
Nucleoli
Mitochondria
Mixed
MAP1AMicrotubule associated protein 1AFDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolTissue enriched
MAP2Microtubule associated protein 2FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoli
Cytosol
Tissue enriched
MAP2K1Mitogen-activated protein kinase kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Plasma membrane
Cytosol
Expressed in all
MAP2K2Mitogen-activated protein kinase kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
CytosolExpressed in all
MAP4Microtubule associated protein 4FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Microtubules
Cytosol
Expressed in all
MAPK1Mitogen-activated protein kinase 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
MAPK11Mitogen-activated protein kinase 11Enzymes
FDA approved drug targets
Predicted intracellular proteins
MitochondriaMixed
MAPK3Mitogen-activated protein kinase 3Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
NucleoplasmExpressed in all
MAPTMicrotubule associated protein tauCandidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nuclear speckles
Plasma membrane
Tissue enriched
MC2RMelanocortin 2 receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
METMET proto-oncogene, receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Plasma membrane
Cytosol
Expressed in all
METAP2Methionyl aminopeptidase 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Expressed in all
MGAMMaltase-glucoamylaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
MMEMembrane metalloendopeptidaseCancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
MMP1Matrix metallopeptidase 1Cancer-related genes
Candidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
VesiclesTissue enhanced
MMP10Matrix metallopeptidase 10Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Plasma membrane
Cytosol
Tissue enriched
MMP11Matrix metallopeptidase 11Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Group enriched
MMP12Matrix metallopeptidase 12Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
MMP13Matrix metallopeptidase 13Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
MMP14Matrix metallopeptidase 14Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Intermediate filaments
Cytosol
Mixed
MMP15Matrix metallopeptidase 15Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Plasma membrane
Cytosol
Tissue enhanced
MMP16Matrix metallopeptidase 16Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Vesicles
Cytosol
Tissue enhanced
MMP17Matrix metallopeptidase 17Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
« prev | Page of 12 | next »